menu
    • menu

    Company profile for I-Mab Biopharma

    Bloomage is a one-stop source for CEP Sodium Hyaluronate and Hyaluronic Acid// FDA-inspected & GMP-certified.

    Virtual Booth

    Contact Supplier

    Metrochem has been delivering customized volume & quality products to customers across the world, taking utmost care of their needs.

    Virtual Booth

    Contact Supplier

    AbbVie CDMO has been working with global companies to develop, manufacture & scale biopharmaceutical products.

    Virtual Booth

    Contact Supplier

    Willow Birch Pharma delivers trusted, high-quality APIs nationwide with unmatched service, compliance, and competitive value.

    Virtual Booth

    Contact Supplier

    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-11-03

    Virtual Booth

    Contact Supplier

    EVENTS

    DIGITAL CONTENT

    DEVELOPMENTS

    PharmaCompass

    Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

    Update your Virtual Booth on PharmaCompass, ask us

    About

    I-Mab Biopharma was established through a merger of Third Venture Biopharma, an innovative antibody start-up, and Tasgen, a joint venture biotech by Tasly Pharmaceuticals, Genexine and C-Bridge Capital. The merged Company now combines novel antibody discovery and regulatory/clinical development expertise from Third Venture Biopharma and Tasgen's unique strength in biologics CMC, QA/QC and pre-clinical development, thus coverin...
    I-Mab Biopharma was established through a merger of Third Venture Biopharma, an innovative antibody start-up, and Tasgen, a joint venture biotech by Tasly Pharmaceuticals, Genexine and C-Bridge Capital. The merged Company now combines novel antibody discovery and regulatory/clinical development expertise from Third Venture Biopharma and Tasgen's unique strength in biologics CMC, QA/QC and pre-clinical development, thus covering the full spectrum of innovative biologics R&D.

    List your booth number for exhibitions, ask us

    CONTACT DETAILS

    Click the arrow to open the dropdown
    Contact SupplierContact
    Google MapGoogle Map
    Full View ScreenFull View Screen
    I-Mab BiopharmaChina Flag
    Country
    Country
    China
    Address
    Address
    Suite 802, West Tower, OmniVision, 88 Shangke Road, Pudong District, Shanghai,...
    Telephone
    Telephone
    86-21-6057 8000
    Client Email
    Email
    enquiries@pharmacompass.com
    Client Website
    Website
    https://www.i-mabbiopharma.com/endpoints-i-mab-a-biotech-on-the-rise-with-inspired-science/
    Linkedin
    Linkedin
    youtube
    YouTube
    Twitter
    Twitter

    Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

    Events

    Webinars & Exhibitions

    Request a meetingRequest a meeting
    Full Screen ViewFull Screen View
    DCAT Week

    DCAT Week

    Not Confirmed

    envelop Contact Supplier

    DCAT Week

    Post an Enquiry

    Meeting

    Digital content

    Create Content with PharmaCompass, ask us

    NEWS #PharmaBuzz

    read-more
    read-more
    I-Mab Rebrands as NovaBridge Biosciences, Trading as NBP Oct 30
    I-Mab Rebrands as NovaBridge Biosciences, Trading as NBP Oct 30

    29 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/29/3176512/0/en/I-MAB-Nasdaq-IMAB-Transitions-to-NovaBridge-Biosciences-Nasdaq-NBP-with-Trading-Effective-October-30-2025-New-Brand-and-Logo-to-Reflect-Strategic-Transformation-to-a-Global-Biotech.html

    GLOBENEWSWIRE
    29 Oct 2025
    Share Share
    I-Mab To Present Updated Givastomig Data At AACR-NCI-EORTC
    I-Mab To Present Updated Givastomig Data At AACR-NCI-EORTC

    22 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/22/3171382/0/en/I-Mab-To-Present-Positive-Updated-Givastomig-Monotherapy-Data-at-2025-AACR-NCI-EORTC-Molecular-Targets-and-Cancer-Therapeutics-Conference-on-October-23-2025.html

    GLOBENEWSWIRE
    22 Oct 2025
    Share Share
    I-Mab Unveils New Name, Strategy, Asset And Hong Kong IPO Plans
    I-Mab Unveils New Name, Strategy, Asset And Hong Kong IPO Plans

    17 Oct 2025

    // FIERCE BIOTECH

    https://www.fiercebiotech.com/biotech/i-mab-undergoes-makeover-new-name-strategy-asset-and-hong-kong-ipo-plans

    FIERCE BIOTECH
    17 Oct 2025
    Share Share
    I-Mab to Rebrand as NovaBridge, Pursue Global Biotech Pivot
    I-Mab to Rebrand as NovaBridge, Pursue Global Biotech Pivot

    16 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/16/3168300/0/en/I-Mab-Announces-Intention-to-Undertake-Strategic-Transformation-to-Global-Biotech-Platform-to-Pursue-Hong-Kong-IPO-and-Rebrand-as-NovaBridge-Biosciences.html

    GLOBENEWSWIRE
    16 Oct 2025
    Share Share
    I-Mab to Present on Updated Givastomig Monotherapy Data
    I-Mab to Present on Updated Givastomig Monotherapy Data

    14 Oct 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/10/14/3166006/0/en/I-Mab-to-Present-Short-Talk-on-Updated-Givastomig-Monotherapy-Data-at-the-2025-AACR-NCI-EORTC-Molecular-Targets-and-Cancer-Therapeutics-Conference.html

    GLOBENEWSWIRE
    14 Oct 2025
    Share Share
    I-Mab Speeds Up Givastomig Investment and Leadership Changes
    I-Mab Speeds Up Givastomig Investment and Leadership Changes

    08 Sep 2025

    // GLOBENEWSWIRE

    https://www.globenewswire.com/news-release/2025/09/08/3146094/0/en/I-Mab-Announces-Acceleration-of-Givastomig-Investment-and-Leadership-Appointments.html

    GLOBENEWSWIRE
    08 Sep 2025
    Share Share

    ABOUT THIS PAGE

    Ask Us for Pharmaceutical Supplier and Partner
    Ask Us, Find A Supplier / Partner
    No Commissions, No Strings Attached, Get Connected for FREE

    What are you looking for?

    How can we help you?

    The request can't be empty

    Please read our Privacy Policy carefully

    You must agree to the privacy policy

    The name can't be empty
    The company can't be empty.
    The email can't be empty Please enter a valid email.
    The mobile can't be empty
    • Privacy policy
    • Terms and conditions
    • Disclaimers
    • LinkedIn
    • Product listings are provided for informational purposes only. We do not supply or sell any products. Any products that may be covered by patent(s) are supplied solely for uses permitted under Section 107A of the Indian Patents Act and not for commercial sale.

    Market Place

    Market Place

    PharmaCompass

    Home

    Market Place

    Menu

    Post Enquiry

    Post Enquiry

    Market Place

    Market Place

    Search